Boston Business Journal (blog) |
Seventh Sense aims to upend blood testing as Theranos struggles
Boston Business Journal (blog) The 8-year-old Medford company, backed by Flagship Venture, hopes its TAP Touch Activated Phlebotomy device stands to achieve what's so far eluded Palo Alto, California-based Theranos: the development of an effective blood test that work with just one ... Seventh Sense Biosystems Launches Pivotal Trial For Groundbreaking TAP Diagnostic Blood Collection Device |
from phlebotomy - Google News http://bit.ly/22tScnB
No comments:
Post a Comment